Basilea announces start of clinical study by partner Asahi Kasei Therapeutics in Japan with antifungal Cresemba(R) (isavuconazole) in pediatric patients
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.